Our latest news
Aiosyn was awarded a NWO Take-off Phase 2 project
Aiosyn, a company that develops AI-powered pathology algorithms for clinical diagnostics and life sciences, was awarded early-phase funding of Eur 250.000 by NWO (Dutch Research Council). This additional funding allows Aiosyn to accelerate its mission: increasing the adoption of artificial intelligence in pathology diagnostics and improving the chances of …
Aiosyn receives a PPP project to improve breast and prostate cancer grading
Aiosyn, a company that develops AI-powered pathology algorithms, will participate in an Health~Holland PPP Allowance project with the main aim to improve the diagnostic process for breast and prostate cancer grading.
Aiosyn has been selected for Techleap’s Pole Position Program
We are thrilled and excited to have been selected for the first edition of Techleap’s Pole Position. This new initiative will help us grow faster by providing access to the best network of medtech experts and investors, as well as by facilitating peer-to-peer learning throughout a number of interactive …
New start-up Aiosyn will bring AI research into pathology diagnostics
Aiosyn is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Aiosyn is a spin-off from Radboudumc, a frontrunner in computational pathology research.
Digital workflow as an essential prerequisite for AI in pathology [AI for Life Podcast]
[Only Dutch version available]
In de zevende aflevering van de podcast 'AI for Life' staat het onderwerp computational pathology centraal. Katrien Grünberg, Jeroen van der Laak (beiden van het Radboudumc) en Patrick de Boer (medeoprichter van Aiosyn, een startup op basis van kennis die in het Radboudumc is ontwikkeld) spreken …